CLOU vs XBI
Global X Cloud Computing ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.68% for CLOU.
- • XBI pays a higher dividend yield (0.35%).
Side-by-side metrics
| Metric | CLOU | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.68% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $399M | $10.92B |
YTD return | 15.61% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.04 | 1.01 |
P/E ratio | 29.48 | — |
Last price | $26.61 | $156.41 |
Inception | — | — |
Issuer | Global X | State Street |
CLOU top holdings
| SNOW | Snowflake Inc Ordinary Shares | 6.57% |
| PAYC | Paycom Software Inc | 6.11% |
| ZS | Zscaler Inc | 5.33% |
| DDOG | Datadog Inc Class A | 5.21% |
| QLYS | Qualys Inc | 4.94% |
| WDAY | Workday Inc Class A | 4.73% |
| TWLO | Twilio Inc Class A | 4.06% |
| NET | Cloudflare Inc | 4.01% |
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 3.81% |
| CRM | Salesforce Inc | 3.81% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About CLOU
CLOU (Global X Cloud Computing ETF) is Cloud computing infrastructure and platform companies. Managed by Global X, the fund carries $399M in assets under management, an expense ratio of 0.68%. Its largest holding is Snowflake Inc Ordinary Shares (SNOW), which represents 6.6% of the portfolio. Real Estate is the fund's largest sector exposure at 2.6%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.